SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Isotechnika
An SI Board Since August 2001
Posts SubjectMarks Bans Symbol
285 8 0 ISA
Emcee:  schzammm Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
135Jason It has to do with FDA's agreement that they may now proceed with one Icebrg-2/25/2004
134Eric, this is the first mention I recall of trans-ISA247. Have you seen this metnsaf-2/25/2004
133FDA Agrees to Clinical Development Plans for ISA247 Wednesday February 25, 8:00 Icebrg-2/25/2004
132Brewing hope for transplants By Christopher Rowland, Globe Staff, 2/23/2004 ItIcebrg-2/23/2004
131change in guidance ISOTECHNIKA INC (ISA : TSX : C$3.00) - BUY - 12-MONTH TARGETteevee-2/20/2004
130ISA states <i>Pre- clinical studies of TKB662 have demonstrated inhibitionteevee-2/19/2004
129Icebrg, I'm not sure this is good news. Can we be sure the new single isometeevee-2/19/2004
128Isotechnika Inc. - FDA Agrees to Manufacturing Plans for ISA247 Thursday FebruarIcebrg-2/19/2004
127Immunosuppression [Some historical perspectives from the article: Transplants: Icebrg-2/10/2004
126Isotechnika eyes breath test as early diabetes predictor Medical Device Daily FeIcebrg-2/9/2004
125Isotechnika granted United States patent for Cyclosporine antibodies Monday FebrIcebrg-2/9/2004
124Isotechnika Inc. - Diatest Results Published in Current Issue of Diabetes Care WIcebrg-1/28/2004
123Although somewhat dated, this article provides a little more insight into how ISteevee-1/13/2004
122teevee, thanks for the PR. What are you up to these days? I see you pop up everyschzammm-1/5/2004
121Isotechnika Announces New Appointment Monday January 5, 9:30 am ET EDMONTON, Jteevee-1/5/2004
120Yatscoff Interview We have a new video clip type of interview with Yatscoff on Icebrg-12/6/2003
119Sirolimus reduces significant GvHD in stem cell transplant A trial in mismatchedIcebrg-12/3/2003
118Reuters Isotechnika adds 3rd drug to development pipeline Tuesday December 2, 3:schzammm-12/2/2003
1173rd quarter report and letter to shareholders: sedar.comteevee-11/28/2003
116<i> In any event, given the high cost, modest efficacy and less favourableIcebrg-11/7/2003
115teevee, thanks for the article. IMHO ISA has made all their milestones to date, schzammm-11/4/2003
114Potential New Pfizer Medicine Reduces Transplant Rejection Rates in Animal Studiteevee-10/31/2003
113Canadian biotech firm picks Valley for U.S. HQ Angela Gonzales The Business JourIcebrg-10/27/2003
112New Life for old molecules. isotechnika.comIcebrg-10/23/2003
111United States Patent Application 20030187015 Kind Code A1 Yatscoff, Randall W.teevee-10/2/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News